Search results
Nov 8, 2022 · Tim Walsh ( Republican Party) ran for election to the Colorado State Senate to represent District 20. He lost in the general election on November 8, 2022. Walsh completed Ballotpedia's Candidate Connection survey in 2022. Click here to read the survey answers.
Oct 27, 2022 · Tim Walsh is running against Democrat Lisa Cutter in a competitive race that could determine which party controls the Colorado Senate next year. The district is a political bellwether for the state and has drawn more than $4.5 million in campaign spending.
Oct 14, 2022 · Tim Walsh is a business owner and a former Army officer running for Colorado State Senate District 20. He supports reducing regulations, fees, and taxes to make housing, healthcare, and energy affordable, and criminalizing fentanyl possession.
People also ask
Who is Tim Walsh?
What did Tim Walsh omit from his personal financial disclosure?
Who are Lynn Emrick & Tim Walsh?
Did Tim Walsh talk about abortion?
Sep 7, 2022 · A complaint alleges that Tim Walsh, a wealthy property developer and Republican nominee for SD20, omitted a financial trust, a corporation, and a mountain home worth more than $3 million from his personal financial disclosure. The complaint could have legal and political implications for Walsh in a close race for control of the state Senate.
Oct 28, 2022 · Tim Walsh is a developer and Republican running for state Senate in District 20, where he is challenging Democrat Lisa Cutter, a state representative. The district is one of seven competitive state Senate districts on the ballot in November. Walsh and Cutter are fighting over issues such as affordability, education and abortion.
Nov 4, 2023 · Golden developer Tim Walsh, who poured over $1 million into his failed race for a state senate seat in Jefferson County last year, is investing in politics again, albeit on a smaller scale. He spent just over $18,000 in support of the slate of conservative Jeffco School Board candidates.
Professor of Medical Microbiology. Research Interests. Publications. Group Members. Contact Details. I have been studying antimicrobial resistance (AMR) mechanisms for over 25 years and regularly publish in Nature and Lancet journals. My primary interests are: The use of antimicrobials in animals and its impact of human clinical failures.
